| Antiretroviral prophylaxis for HIV prevention in heterosexual men and women JM Baeten, D Donnell, P Ndase, NR Mugo, JD Campbell, J Wangisi, ... New England journal of medicine 367 (5), 399-410, 2012 | 3920 | 2012 |
| Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa R Viana, S Moyo, DG Amoako, H Tegally, C Scheepers, CL Althaus, ... Nature 603 (7902), 679-686, 2022 | 1588 | 2022 |
| Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis D Donnell, JM Baeten, J Kiarie, KK Thomas, W Stevens, CR Cohen, ... The Lancet 375 (9731), 2092-2098, 2010 | 1275 | 2010 |
| Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study N Wolter, W Jassat, S Walaza, R Welch, H Moultrie, M Groome, ... The Lancet 399 (10323), 437-446, 2022 | 1106 | 2022 |
| Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study SE Dorman, SG Schumacher, D Alland, P Nabeta, DT Armstrong, B King, ... The Lancet infectious diseases 18 (1), 76-84, 2018 | 717 | 2018 |
| Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2 C Celum, A Wald, JR Lingappa, AS Magaret, RS Wang, N Mugo, ... New England journal of medicine 362 (5), 427-439, 2010 | 630 | 2010 |
| Emergence of SARS-CoV-2 omicron lineages BA. 4 and BA. 5 in South Africa H Tegally, M Moir, J Everatt, M Giovanetti, C Scheepers, E Wilkinson, ... Nature medicine 28 (9), 1785-1790, 2022 | 602 | 2022 |
| Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation NT Funderburg, E Mayne, SF Sieg, R Asaad, W Jiang, M Kalinowska, ... Blood, The Journal of the American Society of Hematology 115 (2), 161-167, 2010 | 352 | 2010 |
| HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study RL Hamers, CL Wallis, C Kityo, M Siwale, K Mandaliya, F Conradie, ... The Lancet infectious diseases 11 (10), 750-759, 2011 | 349 | 2011 |
| Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial I Sanne, C Orrell, MP Fox, F Conradie, P Ive, J Zeinecker, M Cornell, ... The Lancet 376 (9734), 33-40, 2010 | 309 | 2010 |
| Xpert® MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? AV Rie, L Page-Shipp, L Scott, I Sanne, W Stevens Expert review of molecular diagnostics 10 (7), 937-946, 2010 | 307 | 2010 |
| Long-COVID: An evolving problem with an extensive impact M Mendelson, J Nel, L Blumberg, SA Madhi, M Dryden, W Stevens, ... South African Medical Journal 111 (1), 10-12, 2021 | 272 | 2021 |
| Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings GG Sherman, G Stevens, SA Jones, P Horsfield, WS Stevens JAIDS Journal of Acquired Immune Deficiency Syndromes 38 (5), 615-617, 2005 | 256 | 2005 |
| Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF GJ Churchyard, WS Stevens, LD Mametja, KM McCarthy, V Chihota, ... The Lancet Global Health 3 (8), e450-e457, 2015 | 254 | 2015 |
| Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study LE Scott, K McCarthy, N Gous, M Nduna, A Van Rie, I Sanne, WF Venter, ... PLoS medicine 8 (7), e1001061, 2011 | 242 | 2011 |
| Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa KCE Sigaloff, RL Hamers, CL Wallis, C Kityo, M Siwale, P Ive, ME Botes, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 58 (1), 23-31, 2011 | 237 | 2011 |
| Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a … RL Hamers, R Schuurman, KCE Sigaloff, CL Wallis, C Kityo, M Siwale, ... The Lancet infectious diseases 12 (4), 307-317, 2012 | 236 | 2012 |
| CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa E Karita, N Ketter, MA Price, K Kayitenkore, P Kaleebu, A Nanvubya, ... PloS one 4 (2), e4401, 2009 | 216 | 2009 |
| The impact and cost of scaling up GeneXpert MTB/RIF in South Africa G Meyer-Rath, K Schnippel, L Long, W MacLeod, I Sanne, W Stevens, ... PloS one 7 (5), e36966, 2012 | 207 | 2012 |
| HIV-1 viral load assays for resource-limited settings SA Fiscus, B Cheng, SM Crowe, L Demeter, C Jennings, V Miller, ... PLoS medicine 3 (10), e417, 2006 | 206 | 2006 |
